NLP leader Melax Tech Receives NIAID Award

Melax Tech, a world leader in biomedical Natural Language Processing (NLP) technology, today announced the securing of a Phase One SBIR award focused on developing real-time surveillance of vaccine misinformation from social media platforms using ontology and NLP.

The Phase One SBIR grant, valued at $300,000, has been awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to develop innovative and cutting-edge computational algorithms, including semantic technologies and NLP algorithms to model, extract and synthesize vaccine misinformation from multiple popular social media sources. 

“This is a very real topic affecting culture at present and shows that we as a collective business and group of experts continue to be on the cutting-edge of science in the NLP and AI domain,” said Andre Pontin, CEO at Melax Tech.

Dr. Jingcheng Du, Director of NLP research at Melax Tech, noted, “A major driver for vaccine hesitancy is widespread and uncontrolled vaccine misinformation. As one of its first kinds, we will build deep learning-based NLP algorithms to extract and normalize vaccine misinformation from social media. Furthermore, to engage a broad community, we will develop an interactive visualization to synthesize the vaccine misinformation into a comprehensible format. We are very excited and enthusiastic about this project and its potential to improve public health.” 

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

NLP expert Lisa Gillette is recognized by Continental Who’s Who

PR Newswire

Carbyne Raises $56 Mn to Modernize Emergency Contact Centers

PR Newswire

AKASA’s AI Technology Lead, Byung-Hak Kim, Ph.D., Presents at the Healthcare Natural Language Processing Summit 2021

PR Newswire